RLX Technology Q2 Adj EPADS $0.02 Beats $0.02 Estimate, Sales $86.30M Miss $87.91M Estimate
Portfolio Pulse from Benzinga Newsdesk
RLX Technology reported Q2 adjusted EPADS of $0.02, which met the estimate, but sales of $86.30M missed the $87.91M estimate.
August 16, 2024 | 9:33 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
RLX Technology's Q2 adjusted EPADS of $0.02 met the estimate, but sales of $86.30M missed the $87.91M estimate. This mixed result may lead to short-term volatility in the stock price.
The earnings per share met expectations, which is positive, but the sales miss could be a concern for investors. This mixed result is likely to cause short-term volatility in RLX's stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100